Story perspectives

AI Breakthroughs in Viral Genomes Raise Safety Concerns

1/6/2026

30 4

Summary

Story summary

Researchers led by Bruce J. Wittmann at Microsoft show AI systems can create viral genomes and redesign toxins to bypass DNA safety checks, published in Science.
Work highlights a dual-use dilemma: AI could aid phage therapy for antibiotic resistance while risking bioweapons misuse.
Federal policies link funding to safety standards, underscoring the need for DNA synthesis screening.
Experts advocate shared responsibility among stakeholders to ensure safety evaluations in AI-driven biology.

1 of 1

Story summary

Researchers led by Bruce J. Wittmann at Microsoft show AI systems can create viral genomes and redesign toxins to bypass DNA safety checks, published in Science.
Work highlights a dual-use dilemma: AI could aid phage therapy for antibiotic resistance while risking bioweapons misuse.
Federal policies link funding to safety standards, underscoring the need for DNA synthesis screening.
Experts advocate shared responsibility among stakeholders to ensure safety evaluations in AI-driven biology.